• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

MOLECULAR MECHANISM OF MESANGIAL CELL DYSFUNCTION DUE TO HYPERGLYCEMIA AND GLOMERULAR HYPERTENSION

Research Project

Project/Area Number 10671063
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Metabolomics
Research InstitutionSHIGA UNIVERSITY OF MEDICAL SCIENCE

Principal Investigator

HANEDA Masakazu  SHIGA UNIVERSITY OF MEDICAL SCIENCE, THIRD DEPARTMENT OF MEDICINE, ASSISTANT PROFESSOR, 医学部, 講師 (60164894)

Co-Investigator(Kenkyū-buntansha) KOYA Daisuke  SHIGA UNIVERSITY OF MEDICAL SCIENCE,THIRD DEPARTMENT OF MEDICINE, RESEARCH ASSOCIATES, 医学部, 助手 (70242980)
Project Period (FY) 1998 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥3,800,000 (Direct Cost: ¥3,800,000)
Fiscal Year 2000: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1999: ¥1,000,000 (Direct Cost: ¥1,000,000)
Fiscal Year 1998: ¥2,000,000 (Direct Cost: ¥2,000,000)
KeywordsDiabetic nephropathy / Mesangial cells / Stretch stress / extracellular signal-regulated kinase (ERK) / extracellular matrix protein / TGF-β / cGMP / cAMP / cAMP / メサンギウム細胞 / 細胞外基質 / MAP kinase / ブドウ糖過剰
Research Abstract

Hyperglycemia and glomerular hypertension are considered to be main factors responsible for the development of diabetic nephropathy. Although both factors were found to cause mesangial cell dysfunction, the precise mechanisms have not been fully elucidated yet. In the present study, we clearly demonstrated that mechanical stretch due to glomerular hypertension was able to activate extracellular signal-regulated kinase (ERK) and c-Jun NH2-terminal kinase (JNK) through the activation of protein tyrosine kinase, to increase DNA binding activity of AP-1, and thus to enhance the expression of TGF-β and fibronectin (FN) in mesangial cells. An inhibitor of MEK was able to inhibit stretch-induced increase in DNA binding activity of AP-1 and enhancement of TGF-β and FN production. Since we found that hyperglycemia could activate ERK in protein kinase C (PKC)-dependent manner, the mechanism of ERK activation by both factors seems to be different. Thus, we found the additive effect of hyperglycemia and stretch stress on ERK activation and FN production. Furthermore, we found that the agents which could increase cellular cAMP or cGMP were able to prevent stretch-induced activation of ERK and enhancement of FN production. These results indicate that ERK plays a key role in the development of mesangial cell dysfunction under both hyperglycemia and glomerular hypertension through different mechanisms.

Report

(4 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • 1998 Annual Research Report
  • Research Products

    (4 results)

All Other

All Publications (4 results)

  • [Publications] Ishida T,Haneda M, et al.: "Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase"Diabetes. 48. 595-602 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ishida T, Haneda M, Maeda S, Koya D, Kikkawa R.: "Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase."Diabetes. 48. 595-602 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ishida T et al.: "Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase"Diabetes. 48. 595-602 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ishida T,Haneda M,et al.: "Stretch-induced overproduction of fibronectin in mesangial cells is mediated by the activation of mitogen-activated protein kinase." Diabetes. Vol48 (in press). (1999)

    • Related Report
      1998 Annual Research Report

URL: 

Published: 1998-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi